Moreover, evidence suggests that OSA itself can change the lipid profile [31]; OSA itself exacerbates lipid abnormalities by increasing insulin resistance and inflammatory responses, creating a negative feedback loop [32, 33]. The gene discussed is INS; the disease is obstructive sleep apnea syndrome.